Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non–Small-Cell Lung Cancer

Depierre, A; Milleron, B.; Moro‐Sibilot, Denis; Chevret, Sylvie; Quoix, Élisabeth; Lebeau, B; Braun, Denis; Breton, Jean-Luc; Lemarié, Étienne; Gouva, S.; Paillot, N.; Bréchot, J.-M.; Janicot, Henri; Lebas, F.-X.; Terrioux, Philippe; Clavier, J; Foucher, Pascal; Monchâtre, M; Coëtmeur, D.; Level, Marie-Claude; Leclerc, Pascal; Blanchon, F; Rodier, Jean-Michel; Thiberville, Luc; Villeneuve, Anne; Westeel, Virginie; Chastang, Claude; the French Thoracic Cooperative Group, from

doi:10.1200/jco.2002.20.1.247

Public

Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non–Small-Cell Lung Cancer

Published in Journal of Clinical Oncology • Jan 1, 2002

Authors:

A Depierre

B. Milleron

Denis Moro‐Sibilot

Abstract

PURPOSE: To evaluate whether preoperative chemotherapy (PCT) could improve survival in resectable stage I (except T1N0), II, and IIIA non–small-cell lung cancer (NSCLC). PATIENTS AND METHODS: A randomized trial compared PCT to primary surgery (PRS). PCT consisted of two cycles of mitomycin (6 mg/m 2...

Subject

Medicine

Ifosfamide

Confidence interval

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!